Pixium Vision S.A. 13D/13G Filings for Second Sight Medical Products, Inc. (EYES)

Pixium Vision S.A. 13D and 13G filings for Second Sight Medical Products, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-01-08
5:22 pm
Purchase
2021-01-06 13D Second Sight Medical Products, Inc.
EYES
Pixium Vision S.A. 2,326,295
30.100%
2,326,295increase
(New Position)
Filing